Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-24 @ 1:04 PM
NCT ID:
NCT06190561
Brief Summary:
The purpose of this study is to compare two finished products of PF-07940367 in terms of the uptake into the blood stream.
This study is seeking participants who are:
\- Healthy male or female participants aged 18 years or older.
All participants in this study will receive PF-07940367 once by mouth. The participants may receive different tablets by mouth for PF-07940367.
The study will compare experiences of people receiving two different products of PF-07940367. This will help understand how much PF-07940367 is taken up into the blood for each product given.
Participants will take part in the study for about 112 days. During this time, participants will have to stay onsite for 5 days. There will be up to 2 additional onsite study visits and 3 remote (telephone call) study visits.
Study:
NCT06190561
Study Brief:
Protocol Section:
NCT06190561